Predictive efficacy of nalidixic acid resistance as a marker of fluoroquinolone resistance in Salmonella enterica var Typhi

Indian Journal of Medical Research

Volumn 124, Issue 1, 2006, Pages 105-108

  Ray, Pallab ^a   Sharma, Jyoti ^a   Marak, Rungmei S K ^b   Garg, R K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Fluoroquinolone resistance; Nalidixic acid resistance; Salmonella enterica var Typhi; Typhoid fever

Indexed keywords

AGAR; AMOXICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GATIFLOXACIN; NALIDIXIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DILUTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREDICTION; SALMONELLA ENTERICA; STATISTICAL ANALYSIS; TYPHOID FEVER;

BIOLOGICAL MARKERS; CEFOTAXIME; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; SALMONELLA TYPHI;

EID: 33748122396     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Anderson ES. Smith HP. Chloramphenicol resistance in the typhoid bacillus. Br Med J 1972; 3 : 329-31.
2. The World Health Report, Report of the Director General WHO. Geneva: World Health Organization; 1996.
3. National Committee for Clinical Laboratory Standards: Performance Standards for antimicrobial disc susceptibility tests, 7th ed. Approved standards M2-A6. Wayne Pa: National Committee for Clinical Laboratory Standards; 2000.
4. Threlfall EJ, Ward LR. Decreased susceptibility to ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Emerg Infect Dis 2001; 7: 448-50.
5. Kapil A, Das B. Nalidixic acid susceptibility to screen ciprofloxacin resistance in Salmonella typhi. Indian J Med Res 2002; 115 : 49-54.
6. Wain J, Hoa NT Chinh NT, et al. Quinolone resistant Salmonella typhi in Vietnam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 1997; 25 : 1404-10.
7. Sood S, Kapil A, Das B, Jain Y, Kabra SK. Re-emergence of chloramphenicol sensitive Salmonella typhi. Lancet 1991; 353 : 1241-2.
8. Mandal S, Mandal MD, Pal NK. Antimicrobial resistance pattern of Salmonella typhi isolates in Kolkata, India during 1991-2001: a retrospective study. Jpn J Infect Dis 2002; 55 : 58-9.
9. Gales AC, Sader HS, Mendes RE, Jones RN. Salmonella spp. isolates causing blood stream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis 2002; 44 : 313-8.